NEUREXPERT - Trademark Details
Status: 700 - Registered
Serial Number
86650167
Registration Number
5010851
Word Mark
NEUREXPERT
Status
700 - Registered
Status Date
2016-08-02
Filing Date
2015-06-03
Registration Number
5010851
Registration Date
2016-08-02
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2016-05-17
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
PINO, BRIAN J
Statements
Goods and Services
(Based on Intent to Use) (Based on 44(e)) Scientific apparatus and instruments; apparatus and instruments for pharmaceutical and biological research; apparatus and instruments for cell cultures and stem cells; apparatus and instruments using cell cultures and/or stem cells; apparatus and instruments for research on stem cells; apparatus and instruments for research into regenerative disorders and treatment thereof using cell cultures and/or stem cells; apparatus and instruments for research into stem cells; apparatus and instruments for research into the functional phenotype of stem cells; apparatus and instruments for electrophysiology; apparatus and instruments for electrophysiology and electrophysiological assays and tests; apparatus and instruments for safety testing, new chemical entity screening, automated assay platforms and development of biomarkers; apparatus and instruments for safety testing, new chemical entity screening, automated assay platforms and development of biomarkers all relating to electrophysiology; apparatus and instruments for safety testing, new chemical entity screening, automated assay platforms and development of biomarkers all relating to cell cultures and/or stem cells; apparatus and instruments for the application of cell cultures, stem cells and electrophysiology and related techniques to define the action of novel therapeutics in the central nervous system; apparatus and instruments for neuroscience and translational research for disorders including neurology, neurodegeneration, psychiatry, epilepsy, pain and ophthalmology; apparatus and instruments to research and elucidate the site of action of novel therapeutics within a neuronal network; apparatus and instruments to provide functional and mechanistic data on physiological processes that are or may be affected in central nervous system disorders, such as the mechanisms underlying learning, memory, attention and sensory processing; apparatus and instruments for an in vitro biological model to measure parameters of retinal network activity; apparatus and instruments to define transgenic animal model phenotypes at a cellular and neuronal network level; assays and tests for preclinical research; assays and tests for preclinical research using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for preclinical research; assays and tests for drug discovery; assays and tests for drug discovery using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for drug discovery; assays and tests for research into treatments of nervous system disorders; assays and tests for research into treatments of nervous system disorders using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for research into treatments of nervous system disorders; assays and tests for generating data on biological, organic and non-organic chemical compound potency and efficacy, biological, organic and non-organic chemical mechanism of action, and biological, organic and non-organic chemical functional and mechanistic data; assays and tests for generating data on biological, organic and non-organic chemical compound potency and efficacy, biological, organic and non-organic chemical mechanism of action, and biological, organic and non-organic chemical functional and mechanistic data using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for generating data on biological, organic and non-organic chemical compound potency and efficacy, biological, organic and non-organic chemical mechanism of action, and biological, organic and non-organic chemical functional and mechanistic data; assays and tests for generating data on neural mechanisms underlying higher brain functions, including cognition, attention and sensory processing; assays and tests for generating data on neural mechanisms underlying higher brain functions, including cognition, attention and sensory processing; electrophysiology and electrophysiological assays and tests for generating data on neural mechanisms underlying higher brain functions, including cognition, attention and sensory processing using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for measuring biological, organic and non-organic chemical compound potency and efficacy against biological targets coupled to their native transduction pathways and expressed with their naturally occurring subunit conformation and accessory proteins; assays and tests of neuronal function, including synaptic transmission and plasticity; assays and tests of neuronal function, including synaptic transmission and plasticity using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests of neuronal function, including synaptic transmission and plasticity; assays and tests of biological targets in their native environments to provide essential functional and mechanistic data; assays and tests of biological targets in their native environments to provide essential functional and mechanistic data using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests of biological targets in their native environments to provide essential functional and mechanistic data; assays configured to test the effect of biological, organic and non-organic chemical compounds on neuronal function of biological targets, including ligand-gated ion channels, voltage-gated ion channels, G-protein coupled receptors and biological transporters, to confirm mechanism of action; assays configured to test the effect of biological, organic and non-organic chemical compounds on neuronal function of biological targets, including ligand-gated ion channels, voltage-gated ion channels, G-protein coupled receptors and biological transporters, to confirm mechanism of action using cell culture and/or stem cells; electrophysiology and electrophysiological assays configured to test the effect of biological, organic and non-organic chemical compounds on neuronal function of biological targets, including ligand-gated ion channels, voltage-gated ion channels, G-protein coupled receptors and biological transporters, to confirm mechanism of action; magnetic data carriers, recording discs, compact discs, DVDs and other digital recording media containing scientific data; laboratory consumables for assays using cell cultures and/or stem cells and electrophysiology and electrophysiological assays
Goods and Services
Scientific and technological services and research and design relating thereto, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services using cell cultures and/or stem cells to define the action of novel therapeutics in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for electrophysiology and related techniques to define the action of novel therapeutics in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services providing data on biological, organic and non-organic chemical potency, efficacy and mechanism of action at a native biological target in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services measuring biological, organic and non-organic chemical compound potency against biological targets coupled to their native transduction pathways and expressed with their naturally occurring subunit conformation and accessory proteins in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services providing functional and mechanistic data on neural mechanisms that underlie higher brain functions, such as cognition, attention and sensory processing, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services to define the phenotype of transgenic models at the cellular and neuronal network level, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services to produce functional and mechanistic data on the physiological processes that may be affected in central nervous system disorders, such as the mechanisms underlying learning, memory, attention and sensory processing, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on neurophysiological diseases, including psychiatry, neurology, neurodegeneration, epilepsy, pain, ophthalmology and retinal neurodegeneration, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on biological targets, including ligand and voltage gated ion channels, G-protein coupled receptors and biological transporters, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory services to discover and research the biological site of action of novel therapeutics within a cellular and neuronal network, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of assays using cell cultures and/or stem cells, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of electrophysiology and electrophysiological assays, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of laboratory equipment assays using cell cultures and/or stem cells and laboratory consumables therefor, namely, for testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of laboratory equipment for electrophysiology and electrophysiological assays and laboratory consumables therefor, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific research consulting in the field of assays using and/or including cell cultures and/or stem cells; scientific research consulting in the field of electrophysiology and electrophysiological assays; scientific research consulting in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of educational and research project progression for all stages of the drug discovery process; scientific research consulting in the field of educational and research study plans in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of analysis and interpretation of experimental findings in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the establishment and setting up of new laboratories; scientific research consulting in the field of the establishment and setting up of new laboratories using and/or including cell cultures and/or stem cells; scientific research consulting in the field of the establishment and setting up of new electrophysiology laboratories; scientific research consulting in the field of the design and development of assays for diseases and biological targets in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the preparation of data for the pharmaceutical industry; scientific research consulting in the field of the preparation of data for the pharmaceutical industry generated from cell cultures and/or stem cells; scientific research consulting in the field of the preparation of electrophysiological data for the pharmaceutical industry; scientific research consulting in the field of the design and development of assays for drug discovery; scientific research consulting in the field of the design and development of assays using and/or including cell cultures and/or stem cells for drug discovery; scientific research consulting in the field of the design and development of electrophysiology assays for drug discovery; scientific research consulting in the field of assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of assays and tests using and/or including cell cultures and/or stem cells to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of electrophysiology and electrophysiological assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of equipment purchase, and design and assembly of laboratories for in vitro and in vivo assays and tests; scientific research consulting in the field of equipment purchase, and design and assembly of laboratories using and/or including cell cultures and/or stem cells for in vitro assays and tests; scientific research consulting in the field of equipment purchase, and design and assembly of electrophysiology laboratories for in vitro and in vivo assays and tests; scientific research technology consulting services to the pharmaceutical industry on clinical and preclinical research in the fields of electrophysiology, neurophysiology and neuropharmacology; scientific research consulting services in neuroscience and translational research for disorders including neurology, neurodegeneration, psychiatry, epilepsy, pain and ophthalmology; scientific research technology consulting services providing guidance and experimental support for drug discovery research from target identification and validation through to candidate selection and progression to the clinic; scientific research consulting services on all applications of electrophysiology, including safety testing, drug screening, automated platforms and development of functional biomarkers
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2015-06-09
Primary Code
042
First Use Anywhere Date
2013-07-00
First Use In Commerce Date
2013-07-00
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
LISA DUNNER
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
EM | False |
Trademark Events
Event Date | Event Description |
2015-06-06 | NEW APPLICATION ENTERED IN TRAM |
2015-06-09 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2015-09-15 | ASSIGNED TO EXAMINER |
2015-09-15 | ASSIGNED TO LIE |
2015-09-15 | DATA MODIFICATION COMPLETED |
2015-09-22 | NON-FINAL ACTION WRITTEN |
2015-09-22 | NON-FINAL ACTION E-MAILED |
2015-09-22 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2016-03-03 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2016-03-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2016-03-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2016-03-12 | DATA MODIFICATION COMPLETED |
2016-04-05 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2016-04-13 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2016-04-27 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2016-05-17 | PUBLISHED FOR OPPOSITION |
2016-05-17 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2016-08-02 | REGISTERED-PRINCIPAL REGISTER |
2021-08-02 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |